New investments drive cutting-edge R&D in health in Alberta
Genome Canada announces $6M investment for enhancing early-warning systems to promote public health and $2.88M for improving the treatment of autoimmune diseases. From insights to impact we are putting genomics to work on promoting public health. Generating better information on pathogens and other influenza-like illnesses and diseases is vital for supporting decision making by …
New investments drive cutting-edge R&D in health in Alberta Read More »